The described invention provides small molecule anti cancer compounds that selectively target and inhibit measurable biological activity of truncated APC proteins an immortalized Human Colonic Epithelial Cell (HCEC) model and pharmaceutical compositions comprising at least one of the small molecule anti cancer compounds and a pharmaceutically acceptable carrier.